TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) Health Promoting Rehabilitation. A Multimodal Exercise-based Intervention in Patients With Acute Leukaemia Undergoing Re-induction or Consolidation Chemotherapy
Brief Summary: The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.


Options:
A: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise Arm
B: Arm Label: Exercise based multimodal intervention; Type: EXPERIMENTAL; Interventions: Other: Exercise based multimodal intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise based multimodal intervention; Assigned to Arm(s): Exercise based multimodal intervention
C: Arm Label: Exercise in breast cancer survivors; Type: EXPERIMENTAL; Interventions: Behavioral: Combined aerobic and strength exercise training | Arm Label: No exercise in breast cancer survivors; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise in healthy subjects; Type: SHAM_COMPARATOR; Interventions: Behavioral: Combined aerobic and strength exercise training | Intervention Type: BEHAVIORAL; Name: Combined aerobic and strength exercise training; Assigned to Arm(s): Exercise in breast cancer survivors, Exercise in healthy subjects
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical exercise | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): 1, 2, 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) Health Promoting Rehabilitation. A Multimodal Exercise-based Intervention in Patients With Acute Leukaemia Undergoing Re-induction or Consolidation Chemotherapy
Brief Summary: The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.


Options:
A: Arm Label: Fatigued patients: Immediate start CBT; Type: OTHER; Interventions: Behavioral: immediate CBT | Arm Label: fatigues patients: delayed CBT (after 6 months); Type: OTHER; Interventions: Behavioral: Delayed CBT | Arm Label: non-fatiqued controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: immediate CBT; Assigned to Arm(s): Fatigued patients: Immediate start CBT | Intervention Type: BEHAVIORAL; Name: Delayed CBT; Assigned to Arm(s): fatigues patients: delayed CBT (after 6 months)
B: Arm Label: Exercise based multimodal intervention; Type: EXPERIMENTAL; Interventions: Other: Exercise based multimodal intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise based multimodal intervention; Assigned to Arm(s): Exercise based multimodal intervention
C: Arm Label: Arm I (Control); Type: ACTIVE_COMPARATOR; Interventions: Other: questionnaire administration, Procedure: quality-of-life assessment, Procedure: management of therapy complications | Arm Label: Arm II (Exercise); Type: EXPERIMENTAL; Interventions: Other: questionnaire administration, Procedure: quality-of-life assessment, Procedure: management of therapy complications, Behavioral: exercise intervention | Intervention Type: OTHER; Name: questionnaire administration; Assigned to Arm(s): Arm I (Control), Arm II (Exercise) | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): Arm I (Control), Arm II (Exercise) | Intervention Type: PROCEDURE; Name: management of therapy complications; Assigned to Arm(s): Arm I (Control), Arm II (Exercise) | Intervention Type: BEHAVIORAL; Name: exercise intervention; Assigned to Arm(s): Arm II (Exercise)
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised Exercise Training Program | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Supervised Exercise Training Program; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Maternal Metabolic Abnormalities in Pregnancy on Human Milk and Subsequent Infant Metabolic Development
Brief Summary: Childhood obesity is on the rise and is a major risk factor for type 2 diabetes later in life. Recent evidence indicates that abnormalities that increase risk for diabetes may be initiated early in infancy. Since the offspring of women with diabetes have an increased long-term risk for obesity and type 2 diabetes, the impact of maternal metabolic abnormalities on early nutrition and infant metabolic trajectories is of considerable interest. The purpose of the study is to investigate the impact of maternal nutrition and metabolic abnormalities in pregnancy on human milk and subsequently on infant health over the first year of life.


Options:
A: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise
B: Arm Label: myo-inositol; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: myo-inositol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: folic acid 400 mcg | Intervention Type: DIETARY_SUPPLEMENT; Name: myo-inositol; Assigned to Arm(s): myo-inositol | Intervention Type: OTHER; Name: folic acid 400 mcg; Assigned to Arm(s): placebo
C: Arm Label: Myo-inositol powder; Type: EXPERIMENTAL; Interventions: Dietary Supplement: inositol + folic acid | Arm Label: Myo-inositol soft gel capsules; Type: EXPERIMENTAL; Interventions: Dietary Supplement: inositol + folic acid | Arm Label: Folic acid; Type: PLACEBO_COMPARATOR; Interventions: Drug: Folic Acid | Intervention Type: DIETARY_SUPPLEMENT; Name: inositol + folic acid; Assigned to Arm(s): Myo-inositol powder | Intervention Type: DIETARY_SUPPLEMENT; Name: inositol + folic acid; Assigned to Arm(s): Myo-inositol soft gel capsules | Intervention Type: DRUG; Name: Folic Acid; Assigned to Arm(s): Folic acid
D: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Maternal Metabolic Abnormalities in Pregnancy on Human Milk and Subsequent Infant Metabolic Development
Brief Summary: Childhood obesity is on the rise and is a major risk factor for type 2 diabetes later in life. Recent evidence indicates that abnormalities that increase risk for diabetes may be initiated early in infancy. Since the offspring of women with diabetes have an increased long-term risk for obesity and type 2 diabetes, the impact of maternal metabolic abnormalities on early nutrition and infant metabolic trajectories is of considerable interest. The purpose of the study is to investigate the impact of maternal nutrition and metabolic abnormalities in pregnancy on human milk and subsequently on infant health over the first year of life.


Options:
A: N/A
B: Arm Label: Nutritional counseling & self blood glucose monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: nutritional counseling, Behavioral: self blood glucose monitoring | Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: nutritional counseling; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring | Intervention Type: BEHAVIORAL; Name: self blood glucose monitoring; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring
C: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise
D: Arm Label: Lifestyle intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Exercise / Physical Activity | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical Exercise / Physical Activity; Assigned to Arm(s): Lifestyle intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partnering With Media and Vaccination Program to Improve Infant and Young Child Feeding
Brief Summary: Infant and young child feeding (IYCF) is a key determinant of under-nutrition and overweight in young children. In Mexico, breastfeeding extends well into the second half of infancy, but animal-source foods, cereals, and legumes are not regularly provided to the child by 9 mo. This study evaluates whether knowledge and practices about dietary diversity and food consistency can be improved using a two-component intervention strategy in semi-urban communities in Mexico. The two components will deliver appropriate complementary feeding messages using: (a) nurses during the 1st National Vaccination Week (NVW); and (b) radio messages and interviews. The intervention is evaluated using a cluster randomized design in small semi-urban communities in two states in Mexico with pre- and post-test questionnaires designed to assess changes in feeding behaviors.


Options:
A: Arm Label: Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
C: Arm Label: National Vaccine Program Plus Radio; Type: EXPERIMENTAL; Interventions: Behavioral: Appropriate complementary feeding messages | Arm Label: Comparison (no intervention); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Appropriate complementary feeding messages; Assigned to Arm(s): National Vaccine Program Plus Radio
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Food and Physical Activity Environments | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Comparison Group | Intervention Type: BEHAVIORAL; Name: Healthy Food and Physical Activity Environments; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Comparison Group; Assigned to Arm(s): Comparison

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partnering With Media and Vaccination Program to Improve Infant and Young Child Feeding
Brief Summary: Infant and young child feeding (IYCF) is a key determinant of under-nutrition and overweight in young children. In Mexico, breastfeeding extends well into the second half of infancy, but animal-source foods, cereals, and legumes are not regularly provided to the child by 9 mo. This study evaluates whether knowledge and practices about dietary diversity and food consistency can be improved using a two-component intervention strategy in semi-urban communities in Mexico. The two components will deliver appropriate complementary feeding messages using: (a) nurses during the 1st National Vaccination Week (NVW); and (b) radio messages and interviews. The intervention is evaluated using a cluster randomized design in small semi-urban communities in two states in Mexico with pre- and post-test questionnaires designed to assess changes in feeding behaviors.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
B: Arm Label: motivational counseling; Type: EXPERIMENTAL; Interventions: Behavioral: motivational counseling | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: motivational counseling; Assigned to Arm(s): motivational counseling
C: Arm Label: Eating and physical activity counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Eating and physical activity counseling | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Eating and physical activity counseling; Assigned to Arm(s): Eating and physical activity counseling
D: Arm Label: National Vaccine Program Plus Radio; Type: EXPERIMENTAL; Interventions: Behavioral: Appropriate complementary feeding messages | Arm Label: Comparison (no intervention); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Appropriate complementary feeding messages; Assigned to Arm(s): National Vaccine Program Plus Radio

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partnering With Media and Vaccination Program to Improve Infant and Young Child Feeding
Brief Summary: Infant and young child feeding (IYCF) is a key determinant of under-nutrition and overweight in young children. In Mexico, breastfeeding extends well into the second half of infancy, but animal-source foods, cereals, and legumes are not regularly provided to the child by 9 mo. This study evaluates whether knowledge and practices about dietary diversity and food consistency can be improved using a two-component intervention strategy in semi-urban communities in Mexico. The two components will deliver appropriate complementary feeding messages using: (a) nurses during the 1st National Vaccination Week (NVW); and (b) radio messages and interviews. The intervention is evaluated using a cluster randomized design in small semi-urban communities in two states in Mexico with pre- and post-test questionnaires designed to assess changes in feeding behaviors.


Options:
A: Arm Label: Entree energy density 100%; Type: EXPERIMENTAL; Interventions: Other: Energy density feeding study | Arm Label: Entree energy density 85%; Type: EXPERIMENTAL; Interventions: Other: Energy density feeding study | Arm Label: Entree energy density 75%; Type: EXPERIMENTAL; Interventions: Other: Energy density feeding study | Intervention Type: OTHER; Name: Energy density feeding study; Assigned to Arm(s): Entree energy density 100%, Entree energy density 75%, Entree energy density 85%
B: Arm Label: Group One (Two-year Intervention, 2016 Enrollment); Type: EXPERIMENTAL; Interventions: Behavioral: CO-CSA plus Nutrition Education | Arm Label: Group Two (Delayed Two-year Intervention, 2016 Enrollment); Type: EXPERIMENTAL; Interventions: Behavioral: CO-CSA plus Nutrition Education | Arm Label: Group Three (One-year Intervention, 2017 Enrollment); Type: EXPERIMENTAL; Interventions: Behavioral: CO-CSA plus Nutrition Education | Arm Label: Group Four (Delayed One-year Intervention, 2017 Enrollment); Type: EXPERIMENTAL; Interventions: Behavioral: CO-CSA plus Nutrition Education | Intervention Type: BEHAVIORAL; Name: CO-CSA plus Nutrition Education; Assigned to Arm(s): Group Four (Delayed One-year Intervention, 2017 Enrollment), Group One (Two-year Intervention, 2016 Enrollment), Group Three (One-year Intervention, 2017 Enrollment), Group Two (Delayed Two-year Intervention, 2016 Enrollment)
C: Arm Label: Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program
D: Arm Label: National Vaccine Program Plus Radio; Type: EXPERIMENTAL; Interventions: Behavioral: Appropriate complementary feeding messages | Arm Label: Comparison (no intervention); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Appropriate complementary feeding messages; Assigned to Arm(s): National Vaccine Program Plus Radio

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Partnering With Media and Vaccination Program to Improve Infant and Young Child Feeding
Brief Summary: Infant and young child feeding (IYCF) is a key determinant of under-nutrition and overweight in young children. In Mexico, breastfeeding extends well into the second half of infancy, but animal-source foods, cereals, and legumes are not regularly provided to the child by 9 mo. This study evaluates whether knowledge and practices about dietary diversity and food consistency can be improved using a two-component intervention strategy in semi-urban communities in Mexico. The two components will deliver appropriate complementary feeding messages using: (a) nurses during the 1st National Vaccination Week (NVW); and (b) radio messages and interviews. The intervention is evaluated using a cluster randomized design in small semi-urban communities in two states in Mexico with pre- and post-test questionnaires designed to assess changes in feeding behaviors.


Options:
A: Arm Label: No food; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Plumpy Doz; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Plumpy Doz | Arm Label: Wheat Soy Blend (WSB++); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Wheat Soy Blend (WSB++) | Arm Label: Chickpea based complementary food supplement; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Chickpea based complementary food supplement | Arm Label: Rice based complementary food supplement; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Rice based complementary food supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Wheat Soy Blend (WSB++); Assigned to Arm(s): Wheat Soy Blend (WSB++) | Intervention Type: DIETARY_SUPPLEMENT; Name: Chickpea based complementary food supplement; Assigned to Arm(s): Chickpea based complementary food supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Rice based complementary food supplement; Assigned to Arm(s): Rice based complementary food supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Plumpy Doz; Assigned to Arm(s): Plumpy Doz
B: Intervention Type: BEHAVIORAL; Name: Nutritional and life style counseling; Assigned to Arm(s): N/A
C: Arm Label: National Vaccine Program Plus Radio; Type: EXPERIMENTAL; Interventions: Behavioral: Appropriate complementary feeding messages | Arm Label: Comparison (no intervention); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Appropriate complementary feeding messages; Assigned to Arm(s): National Vaccine Program Plus Radio
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 3

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II, Randomized, Placebo-Controlled, Parallel-group, Double-Blind, Dose Response Finding Clinical Trial to Study the Efficacy and Safety of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance Who Have Inadequate Glycemic Control on Diet/Exercise Therapy
Brief Summary: This study is being done to evaluate the safety, efficacy, and dose level of sitagliptin (MK-0431/ONO-5435) used once daily (qd) in Japanese participants with impaired glucose tolerance who have inadequate glycemic control using diet and exercise therapy.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo for Sitagliptin 25 mg, Drug: Placebo for Sitagliptin 50 mg | Arm Label: Sitagliptin 25 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo for Sitagliptin 50 mg, Drug: Sitagliptin 25 mg | Arm Label: Sitagliptin 50 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo for Sitagliptin 25 mg, Drug: Sitagliptin 50 mg | Intervention Type: DRUG; Name: Placebo for Sitagliptin 25 mg; Assigned to Arm(s): Placebo, Sitagliptin 50 mg | Intervention Type: DRUG; Name: Placebo for Sitagliptin 50 mg; Assigned to Arm(s): Placebo, Sitagliptin 25 mg | Intervention Type: DRUG; Name: Sitagliptin 25 mg; Assigned to Arm(s): Sitagliptin 25 mg | Intervention Type: DRUG; Name: Sitagliptin 50 mg; Assigned to Arm(s): Sitagliptin 50 mg
B: Arm Label: Exenatide; Type: EXPERIMENTAL; Interventions: Drug: Exenatide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Normal Saline | Intervention Type: DRUG; Name: Exenatide; Assigned to Arm(s): Exenatide | Intervention Type: OTHER; Name: Normal Saline; Assigned to Arm(s): Placebo
C: Arm Label: Exenatide first, then Placebo; Type: EXPERIMENTAL; Interventions: Drug: Exenatide, Drug: Placebo | Arm Label: Placebo first, then Exenatide; Type: EXPERIMENTAL; Interventions: Drug: Exenatide, Drug: Placebo | Intervention Type: DRUG; Name: Exenatide; Assigned to Arm(s): Exenatide first, then Placebo, Placebo first, then Exenatide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Exenatide first, then Placebo, Placebo first, then Exenatide
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: liraglutide; Type: ACTIVE_COMPARATOR; Interventions: Drug: liraglutide | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): liraglutide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo

Answer: A